Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paritat Watiktinkorn

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Neuroscience Letters|July 25, 2013
Genetic variation of GRIN1 confers vulnerability to methamphetamine-dependent psychosis in a Thai populationRachanee Chanasong, Samur Thanoi, Paritat Watiktinkorn, et al.
Pharmacogenomics|December 15, 2016
Association of polymorphisms in GAD1 and GAD2 genes with methamphetamine dependenceSiriluk Veerasakul, Paritat Watiktinkorn, Samur Thanoi, et al.
Human Psychopharmacology|February 26, 2016
Does elevated peripheral benzodiazepine receptor gene expression relate to cognitive deficits in methamphetamine dependence?Siriluk Veerasakul, Samur Thanoi, Paritat Watiktinkorn, et al.
Journal of Psychopharmacology (Oxford, England)|January 18, 2018
Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosisSri-Arun Iamjan, Samur Thanoi, Paritat Watiktinkorn, et al.
Pharmacogenomics|September 25, 2015
BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependenceSri-Arun Iamjan, Samur Thanoi, Paritat Watiktinkorn, et al.
Epigenomics|May 19, 2021
Changes of <i>BDNF</i> exon IV DNA methylation are associated with methamphetamine dependenceSri-Arun Iamjan, Samur Thanoi, Paritat Watiktinkorn, et al.
Pharmacogenomics|August 25, 2017
Increased DNA methylation in the parvalbumin gene promoter is associated with methamphetamine dependenceSiriluk Veerasakul, Paritat Watiktinkorn, Samur Thanoi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Neuroscience Letters|July 25, 2013
Genetic variation of GRIN1 confers vulnerability to methamphetamine-dependent psychosis in a Thai populationRachanee Chanasong, Samur Thanoi, Paritat Watiktinkorn, et al.
Pharmacogenomics|December 15, 2016
Association of polymorphisms in GAD1 and GAD2 genes with methamphetamine dependenceSiriluk Veerasakul, Paritat Watiktinkorn, Samur Thanoi, et al.
Human Psychopharmacology|February 26, 2016
Does elevated peripheral benzodiazepine receptor gene expression relate to cognitive deficits in methamphetamine dependence?Siriluk Veerasakul, Samur Thanoi, Paritat Watiktinkorn, et al.
Journal of Psychopharmacology (Oxford, England)|January 18, 2018
Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosisSri-Arun Iamjan, Samur Thanoi, Paritat Watiktinkorn, et al.
Pharmacogenomics|September 25, 2015
BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependenceSri-Arun Iamjan, Samur Thanoi, Paritat Watiktinkorn, et al.
Epigenomics|May 19, 2021
Changes of <i>BDNF</i> exon IV DNA methylation are associated with methamphetamine dependenceSri-Arun Iamjan, Samur Thanoi, Paritat Watiktinkorn, et al.
Pharmacogenomics|August 25, 2017
Increased DNA methylation in the parvalbumin gene promoter is associated with methamphetamine dependenceSiriluk Veerasakul, Paritat Watiktinkorn, Samur Thanoi, et al.
Pageof 1